Renal care involves
complex decisions
about the correct use
of phosphate binders,
calcimimetics and
Vitamin D, but
what is the right
combination for each
specific patient?
MinAlgo users simply enter most recent patient blood corrected calcium,
phosphate and parathyroid hormone
concentrations, plus details of the
current treatment regimen. The Algorithm
analyses this data and returns information
on possible courses of action.
Over 24,000 different input combinations
are covered, with thresholds for mineral
concentrations determined by KDOQI
guidelines or Renal Association guidelines
or the users own custom values.
For security, the MinAlgo system does
not transfer patient names across the
internet, and does not store the data it
receives. A batch process is also available
for processing multiple test values at the
same time.
The benefits of very careful calcium and
phosphate management are avoidance
of the CKD mineral bone disorder
(CKD-MBD), and more importantly, the
reduction of morbidity and mortality in
patients with CKD.
Minalgo delivers:
- Options for the effective management
of hyperparathyroidism
- A secure web based application
available to renal units worldwide
- Management of targets against KDOQI,
UK Renal Association or locally
customised guideline values
- A solution for the numerous paper
algorithms currently available